Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, 11883, Stockholm, Sweden.
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Cardiovasc Diabetol. 2021 Apr 24;20(1):85. doi: 10.1186/s12933-021-01282-x.
To investigate early and long-term outcomes after treatment of carotid artery stenosis in patients with type 2 diabetes (T2D) compared to patients without T2D.
DESIGN/METHOD: This observational nationwide population-based retrospective cohort study investigated all T2D patients treated for carotid stenosis registered in the National Swedish Vascular Surgery and the National Diabetes Registries. Data was collected prospectively for all patients after carotid intervention, during 2009-2015. We estimated crude early (within 30-days) hazard ratios (HRs) risk of stroke and death, and long-term HRs risk, adjusted for confounders with 95% confidence intervals (CIs), for stroke and death and major adverse cardiovascular events (MACE) by using inverse probability of treatment weighting matching.
A total of 1341 patients with T2D and 4162 patients without T2D were included; 89% treated for symptomatic carotid stenosis, 96% with carotid endarterectomy. There was an increased early risk, HRs (95% CI), for stroke in T2D patients 1.65 (1.17-2.32), whereas risk for early death 1.00 (0.49-2.04) was similar in both groups. During a median follow-up of 4.3 (T2D) and 4.6 (without T2D), with a maximum of 8.0 years; after propensity score matching there was an increased HRs (95% CI) of stroke 1.27 (1.05-1.54) and death 1.27 (1.10-1.47) in T2D patients compared to patients without T2D. Corresponding numbers for MACE were 1.21 (1.08-1.35).
Patients with T2D run an increased risk for stroke, death, and MACE after carotid intervention. They also have an increased perioperative risk for stroke, but not for death.
与非 2 型糖尿病(T2D)患者相比,研究 2 型糖尿病患者颈动脉狭窄治疗的早期和长期结局。
本观察性全国基于人群的回顾性队列研究调查了所有在国家瑞典血管外科和国家糖尿病登记处登记的接受颈动脉狭窄治疗的 2 型糖尿病患者。在 2009 年至 2015 年期间,对所有颈动脉介入治疗后的患者进行了前瞻性数据收集。我们使用逆概率治疗加权匹配,估计了未经调整和调整混杂因素后的早期(30 天内)风险比(HR),以评估中风和死亡的风险,以及长期 HR 风险,用于中风和死亡以及主要不良心血管事件(MACE)。
共纳入 1341 例 2 型糖尿病患者和 4162 例非 2 型糖尿病患者;89%为症状性颈动脉狭窄,96%接受颈动脉内膜切除术。2 型糖尿病患者的早期中风风险增加,HR(95%CI)为 1.65(1.17-2.32),而两组的早期死亡风险 1.00(0.49-2.04)相似。在中位数为 4.3(2 型糖尿病)和 4.6(无 2 型糖尿病)的随访期内,最长随访 8.0 年;在倾向评分匹配后,与非 2 型糖尿病患者相比,2 型糖尿病患者的中风 HR(95%CI)为 1.27(1.05-1.54),死亡 HR(95%CI)为 1.27(1.10-1.47),MACE 的相应数字为 1.21(1.08-1.35)。
与非 2 型糖尿病患者相比,2 型糖尿病患者颈动脉介入治疗后中风、死亡和 MACE 的风险增加。他们也有增加围手术期中风风险,但没有增加死亡风险。